The global spread of COVID-19 continues to affect each of us and the communities in which we live in different ways, and we recognize this is a challenging time for everyone. 

As part of our continued commitment to patients worldwide, we have been in ongoing communication with the global patient advocacy community across disease areas – including oncology, cardiovascular, immunology and fibrosis, hematology and multiple sclerosis – to understand how they are being impacted by the current crisis, and what resources they most need in order to continue to fulfill their missions.

Across the board, we have heard from advocates that their biggest concerns are time and capacity constraints, infrastructure needs, and the lasting financial impact from the current crisis. 

Recognizing the urgency of the situation for the global advocacy community, in May 2020, Bristol Myers Squibb and GRYT Health launched the COVID Advocacy Exchange, a virtual platform to unite advocacy organizations, patients and industry leaders in the exchange of information during and beyond the pandemic. More than 25,000 people from 95 countries have visited the Exchange so far. 

This entirely virtual platform convenes advocates to synchronize efforts, facilitate resource sharing with each other, and allow for increased collaboration, both now and over the long-term. 

The COVID Advocacy Exchange currently facilitates live discussions with experts and peers through virtual sessions which are also recorded for on-demand access, as well as an exhibit hall that provides information about various advocacy groups through virtual booths that participants can visit.

Register today and join us for our upcoming sessions. Past session recordings and on-demand resources are available in our virtual exhibit hall, open 24/7.